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Abstract
Background: Hypoxia could lead to microglia activation and inflammatory mediators’ overproduction. These
inflammatory molecules could amplify the neuroinflammatory process and exacerbate neuronal injury. The aim of
this study is to find out whether harpagoside could reduce hypoxia-induced microglia activation.
Methods: In this study, primary microglia cells harvested from neonatal ICR mice were activated by exposure to
hypoxia (1 % O2 for 3 h). Harpagoside had been shown to be no cytotoxicity on microglia cells by MTT assay. The
scavenger effect of harpagoside on hypoxia-enhanced microglial cells proliferation, associated inflammatory genes
expression (COX-II, IL-1β and IL-6 genes) and NO synthesis were also examined.
Results: Hypoxia enhances active proliferation of microglial cells, while harpagoside can scavenge this effect. We find
that harpagoside could scavenge hypoxia-enhanced inflammatory genes expression (COX-2, IL-1β and IL-6 genes) and
NO synthesis of microglial cells. Under 3 h’ hypoxic stimulation, the nuclear contents of p65 and hypoxia inducible
factor-1α (HIF-1α) significantly increase, while the cytosol IκB-α content decreases; these effects can be reversed
by 1 h’s pre-incubation of 10−8 M harpagoside. Harpagoside could decrease IκB-α protein phosphorylation and
inhibit p65 protein translocation from the cytosol to the nucleus, thus suppress NF-κB activation and reduce the
HIF-1α generation.
Conclusion: These results suggested that the anti-inflammatory mechanism of harpagoside might be associated
with the NF-κB signaling pathway. Harpagoside protect against hypoxia-induced toxicity on microglial cells through
HIF-α pathway.
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Background
The central nervous system (CNS) consists of both neu-
rons and non-neuronal glial cells including microglia
and astrocytes; microglia, the resident macrophages of
brain, play critical roles in the maintenance of neural en-
vironment [1]. Microglia cells also appear to play an im-
portant role during normal function of the nervous system.
Under diverse neurological conditions, such as stroke,
Alzheimer’s disease (AD), Parkinson’s disease (PD), and
nerve injury-induced neuropathic pain, or exposure to
toxicological stimuli, microglia will be rapidly activated
[2]. Activated microglial cells display macrophage-like
characteristics including production of pro-inflammatory
cytokines, antigen presentation and phagocytosis [3]. How-
ever, uncontrolled and sustained secretion of inflammatory
cytokines by microglia also trigger neuronal cell death [4].
Inflammatory components related to neuro-inflammation
include microglia and astrocytes, the complement system,
as well as cytokines and chemokines [5].
In Alzheimer’s disease (AD), it has been observed in
epidemiological studies that treatment with non-steroidal
anti-inflammatory drugs (NSAIDs) decreases the risk for
developing AD. Unfortunately, clinical trials of NSAIDs in
AD patients have not been very fruitful. Proinflammatory
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responses may be countered through polyphenols. Supple-
mentation of these natural compounds may provide a new
therapeutic line of approach to this brain disorder [5].
Si-Miao-Yong-An (Trade name: Mai-Luo-Ning), a Chinese
herbal formulation comprising Flos Lonicerae Japonicae,
Radix Scrophulariae Ningpoensis, Radix Angelicae Sinensis
and Radix Glycyrrhizae Uralensis, has been used in treating
ischemic cardiovascular and cerebrovascular diseases for
many years. Clinical and experimental studies have shown
that Si-Miao-Yong-An can inhibit the inflammatory re-
sponse and antagonize the blood clotting process. In the
previous study, there was evidence that Si-Miao-Yong-An
could promote the stability of atherosclerotic plaque in the
rabbit model [6].
Preparations of Harpagophytum procumbens, known as
devil’s claw, are used as an adjunctive therapy for the treat-
ment of pain and osteoarthritis. Pharmacological evalua-
tions have proven the effectiveness of this herbal drug as
an anti-inflammatory and analgesic agent [7]. Harpagoside
is thought to be the active principle and may represent
potential anti-inflammatory drugs [8]. In this study, the
anti-inflammatory activities of the main component of
aqueous extracts from the Radix Scrophulariae, harpago-
side, was evaluated in vitro to investigate their suppressive
effect on the hypoxia-induced microglial cells activation.
Methods
Preparation of microglial cells culture
This study received prior approval of the Taipei Medical
University Investigation Research Board Committee.
Enriched microglial cells culture were derived from the
ICR mice neonatal cortex (3–4 days old) using a tech-
nique modified from Saura et al. that favors the sur-
vival and proliferation of glial cells over neurons [9].
Briefly, mixed glial cultures were prepared from mech-
anical and chemical dissociation, cortical cells were
seeded in DMEM (Life Technologies Inc., Gibco/BRL
Division, Grand Island, New York, USA) with 10 % FBS
(Life Technologies Inc., Gibco/BRL Division, Grand Island,
New York, USA) at a density of 250,000 cells/ml (=62,500
cells/cm2). Cells were cultured at 37 °C in humidified 5 %
CO2/95 % air. Medium was changed every 3 days and con-
fluence of microglial cells culture was achieved after 10–14
days in vitro. Then, microglial cells culture was prepared
by mild trypsinization (0.05 % trypsin + 0.2 mM EDTA)
and shaking. High purity of microglia can be isolated by
shaking off loosely adherent cells (astrocytes) from mixed
glial cultures. For the following study, the microglial cells
were grown in DMEM supplemented with 10 % fetal
bovine serum. The surgical procedures were carried out in
accordance with the Declaration of Helsinki and experi-
mental protocols were approved and under supervision by
the Medical College’s Animal Research Committee of the
Taipei Medical University.
The effects of harpagoside under hypoxic conditions
The incubation under hypoxic (1 % O2) or normoxic condi-
tions was performed with CO2/Tri-gas incubator (ATC-
SMA-30D, Astec, Osaka, Japan). To evaluate the effects of
harpagoside (Biotic Chemical, Lu Chou, New Taipei City,
Taiwan) under hypoxic conditions, the microglial cells were
pre-incubated with harpagoside for 1 h before hypoxic test.
3-[4,5-dimethylthiazol]-2,5-diphenylterazolium bromide
assay (MTT assay)
Microglial cells (1 × 104 cells/well) were seeded into eight
96-well plates. After 2 days of incubation, harpagoside at
concentrations ranging from 10−5 M to 10−9 M was added.
The 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium
bromide (MTT; Sigma Co., St. Louis, MO, USA) assay for
cell viability was performed at the 1st, 3rd, 7th day of cul-
ture. During the experiment, the treatment (including
medium and medication) was changed every 3 days and
fresh harpagoside was added at each media change. The
level of mitochondrial activity of the microglial cells after
harpagoside treatments were determined by colorimetric
assay, which detects the conversion of MTT to insoluble
formazan. The plates were read on the ELISA reader
(Spectra max 340, molecular Devices; CA, USA) at a
wavelength of 595 nm.
RNA extraction, cDNA synthesis, reverse transcriptase
polymerase chain reaction (RT-PCR) and quantitative
real-time PCR
After treatment, RNA for analysis was isolated at different
time points. Briefly, the cell cultures were washed with
PBS, total RNA was extracted and then cDNA reversely
transcripted. PCR amplification was performed by the
Light Cycler FastStart DNA Master SYBR Green I (Roche,
Mannheim, Germany). The amplification was performed
in a Roche Light Cycler 2.0 instrument under the following
condition: initial denaturation at 95 °C for 10 min, 45 cycles
of denaturation at 95 °C for 5 s, annealing at 55 °C for 5 s,
and extension at 72 °C for 8 s. For each genes analysis, the
experiments were repeated at four times. The internal
standard gene used was α-tubulin and the analyzed
genes were listed in Table 1.
Measurement of NO production
Nitrite production in the culture medium was measured
of NO production using nitrate/nitrite colorimetric assay
kit by the Griess reaction. Briefly, 30 μl culture medium
was incubated with 15 μl of 1 % sulfanilamide (Sigma
Chemical, St. Louis, MO, USA) in 5 % phosphoric acid
for 5 min incubation at 37 °C, then added 15 μl of
0.1 % N-1-naphthyl-ethylenediamine dihydrochloride
(Sigma Chemical, St. Louis, MO, USA) in 5 % phosphoric
acid. After a 10 min incubation period at 37 °C, absorbance
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was measured at 550 nm at 37 °C against a blank prepared
with 60 μl of distilled water [10].
Western blot analysis
After treatments, culture medium was discarded and cells
were lysed with Laemmli buffer (4 % SDS, 20 % glycerol,
10 % 2-mercaptoethanol, 0.004 % bromophenol blue,
0.125 M Tris/HCl, pH 6.8). Lysates were boiled for 3 min,
resolved by 10 % SDS/PAGE using Tris-glycine pH 8.3
(25 mM Tris, 192 mM glycine, 0.1 % SDS) as running buf-
fer, and then electroblotted onto a Hybond nitrocellulose
membrane (transfer buffer: 25 mM Tris, 195 mM glycine,
0.05 % SDS, pH 8.3, and 20 % v/v methanol). Non-specific
binding sites on the membrane were blocked (1 h, 25 °C)
using 5 % ECL membrane blocking agent in Tris-buffered
saline (25 mM Tris, 137 mM NaCl, 3 mM KCl, pH 7.4)
containing 0.1 % Tween-20 (TBS-Tween). Blots were
briefly rinsed with two changes of TBS-Tween buffer, and
then washed three times for 10 min each. Afterwards, blots
were incubated with an appropriate dilution of specific
antibodies for 1 h at 4 °C, washed three times for 10 min
each with TBS-Tween, and probed using a 1:1000 dilution
of either anti-mouse or anti-rabbit horseradish peroxidase-
conjugated antibodies for 1 h at 25 °C [11]. After washing,
blots were incubated with the enhanced chemiluminis-
cence substrate (ECL kit) and the bands were detected
using Fujifilm Intelligent Dark Box II equipment coupled to
an LAS-1000 digital camera (Valhalla, NY, USA). IMAGE
READER LAS-1000 and LPROCESS V1.Z2 software were
used to visualize the bands.
Statistical analysis
All experiments were performed at four times. Results
were expressed as mean ± standard deviation of these
expe"riments and statistically analyzed by Two-way
ANOVA. Statistical significance by Dunnett’s test was set at
p < 0.05 between the means of the control and test groups.
Results
Harpagoside do not affect microglial cells viability
The effect of harpagoside on microglial cells viability
was examined at harpagoside concentrations of 0, 10−5,
10−6, 10−7, 10−8, and 10−9 M at 1, 3, and 7 days of cul-
ture (n = 4; Fig. 1). In this study, there is significant
difference observed between treated cells and that of the
control (p < 0.05). We chose 10−8 M harpagoside for
further evaluation because there was maximal viability
of microglial cells at this concentration (112.9 % of con-
trol, p < 0.01) at the 1st day’s culture.
Harpagoside scavenge hypoxia-enhanced microglial cells
active proliferation
Under hypoxia condition (1 % O2), active proliferation of
microglial cells was observed when compared with that of
normoxic control (n = 4; Fig. 1). With 1 h pre-incubation
with harpagoside, hypoxia-enhanced active proliferation of
microglial cells was scavenged (n = 4; Fig. 1).
Harpagoside scavenge hypoxia-enhanced microglial cells
activation
Three hours’ hypoxia stimulates microglial cells to up-
regulate their cyclooxygenase-2 (COX-2), interleukins
(IL-1β and IL-6) genes expression, with its maximal
effect occurred at 6 h’ culture; while for the tumor ne-
crosis factor (TNF-α) gene, its maximal effect was at
0 h’ culture. The pre-incubation of 10−8 M harpagoside
again can inhibit these effects (Figs. 2 and 3).
Harpagoside scavenge hypoxia-enhanced NO synthesis of
microglial cells
Three hours’ hypoxia stimulates microglial cells iInduci-
ble nitric oxide synthase (iNOS) gene expression; iNOS
gene expression significantly upregulated with its maximal
effect occurred at 6 h’ culture (up to 23.9 folds of the con-
trol). The pre-incubation of harpagoside can down-regulate
hypoxia-induced iNOS gene expression with its maximal
effect occurred at 24 h’ culture (down to 0.1 folds of the
control) (Fig. 4). Besides, we found that when microglial
cells cultured under hypoxia condition (1 % O2), active
synthesis of NO was observed, this attained its maximal ef-
fect at 24 h’ culture (up to 127.2 % of the control). While
1 h pre-incubation with harpagoside on microglial cells
does reduce the NO production by microglial cells under
hypoxic condition, which attained its maximal effect at
24 h’ culture (down to 85.5 % of the control) (n = 4; Fig. 4).
Table 1 Primers sequences for reverse transcription–polymerase
chain reaction (RT–PCR)
Gene name Primer Product
(bp)(Gene bank) (F:sense primer/R: antisense primer)
IL-1β F: 5′- GTGTGTGACGTTCCCATTAGA -3′ 101
(NM8361) R: 5′- AGGTGGAGAGCTTTCAGCTCA -3′
IL-6 F: 5′- CAAGTCGGAGGCTTAAAC -3′ 101
(X54542) R: 5′- AAGTGCATCATCGTTGTTCAT -3′
TNF-α F: 5′- TCTCTACCTTGTTGCCTCCTCTTTT -3′ 150
(NM013693.1) R: 5′- TGTAGGGCAATTACAGTCACGG -3′
COX-2 F: 5′- CTGACCCCCAAGGCTCCA -3′ 94
(NM011198) R: 5′- CCAGGTCCTCGCTTATGA -3′
iNOS F: 5′- AACATCAGGTCGGCCATCA -3′ 94
(NM010927) R: 5′- CGTACCGGATGAGCTGTCA -3′
β-miroglobulin F: 5′-TTCAGTGTGAGCCAGGATATAGAAA-3′ 153
(NM009735.3) R: 5′-GAAGCCGAACATACTGAACTGCT-3′
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Fig. 1 Effect of harpagoside on microglial cells viability and scavenger effect on hypoxia-enhanced microglial cells activation. From this study, harpagoside
has no significant cytotoxicity on microglial cells; while there is significant difference observed between treated cells (10−5, 10−6, 10−7, 10−8,
and 10−9 M harpagoside) with that of the control (n = 4; p < 0.05) at 1, 3, and 7 days’ culture. We chose 10−8 M harpagoside for the further
evaluation because there was maximal viability of microglial cells at this concentration (112.9 % of control, p< 0.01) at the 1st day’s culture. Under hypoxia
condition (1 % O2), active proliferation of microglial cells was observed when compared with that of normoxic control (n = 4; p < 0.05). With
1 h pre-incubation with harpagoside, hypoxia-enhanced active proliferation of microglial cells was scavenged (n= 4). Similar to previous results, we chose
10−8 M harpagoside for the further evaluation because there was persistent effect throughout the 1st day’s culture
Fig. 2 Effect of harpagoside on hypoxia-induced inflammatory gene expression (TNF-α, COX-2) of microglial cells. Three hours’ hypoxia stimulates
microglial cells TNF-α and COX-2 genes expression. The maximal effect on COX-2 gene occurred at 6 h’ culture; while for the TNF-α gene, its maximal
effect was at 0 h’ culture. The pre-incubation of 10−8 M harpagoside again can inhibit these effects (n = 4). Note: *: p < 0.05
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Harpagoside suppress hypoxia-induced microglial cells
activation
Under 3 h’ hypoxic stimulation, the nuclear content of tran-
scription factor p65 (RELA) (p65) and hypoxia-inducible
factors (HIF-α) significantly increased; while the cytosol
IκB-α content significantly decreased and the cytosol HIF-α
content remained stationary. These effects can be reversed
by 1 h’s pre-incubation of 10−8 M harpagoside (Fig. 5).
Discussion
During cerebral ischemia, exposure to hypoxia induced
microglia activation; hypoxia may not only directly dam-
age neurons, but also promote neuronal injury indirectly
via microglia activation. Thus, toxic inflammatory medi-
ators produced by activated microglia may exacerbate
neuronal injury following cerebral ischemia [12]. An im-
portant factor in the onset of inflammatory process is
Fig. 3 Effect of harpagoside on hypoxia-induced inflammatory gene expression (IL-1β, IL-6) of microglial cells. Three hours’ hypoxia stimulates
microglial cells IL-1β and IL-6 genes expression, with its maximal effect occurred at 6 h’ culture. The pre-incubation of 10−8 M harpagoside again
can inhibit these effects (n = 4). Note: *: p < 0.05
Fig. 4 Effect of harpagoside on iNOS gene expression and NO synthesis of microglial cells. Three hours’ hypoxia stimulates microglial cells iNOS
gene expression; with its maximal effect occurred at 6 h’ culture; the pre-incubation of harpagoside can down-regulate hypoxia-induced iNOS
gene expression. Besides, we found that when microglial cells cultured under hypoxia condition (1 % O2), active synthesis of NO was observed;
while 1 h pre-incubation with harpagoside on microglial cells does reduce the NO production by microglial cells under hypoxic condition (n = 4).
Note: *: p < 0.05
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the overexpression of interleukin (IL)-1, which may cause
dysfunction and neuronal death in a vicious circle. Other
important cytokines are IL-6 and tumor necrosis factor
(TNF)-α. Thus, therapeutic strategies directed at control-
ling the activation of microglia and astrocytes and the ex-
cessive production of pro-inflammatory and pro-oxidant
factors may be valuable to control neurodegeneration in
AD and dementia [13].
TNF-α plays a central role in the cytokine cascade during
an inflammatory response. Neuronal production of TNF-α
has also been demonstrated [14]. In the central nervous
system (CNS), tumor necrosis factor-alpha (TNF-α) plays a
critical role as an inflammatory mediator. There exist a
positive feedback loop in the activation of microglia via
TNF-alpha; this may be involved in the prolonged acti-
vation of microglia [15]. Inflammation induced by the
generation of prostanoids may well contribute to neuronal
destruction. Although COX-2 expression is driven by
physiological synaptic activity [16] and therefore may
be regarded as physiologically expressed protein in a
subclass of neurons; in this study, we demonstrated that
3 h’ hypoxia stimulates microglial cells to up-regulate their
TNF-α and COX-2 genes expression; while the pre-
incubation of 10−8 M harpagoside again can scavenge
these effects (Fig. 2).
Pharmacological evaluations have proven the effective-
ness of harpagoside as an anti-inflammatory and analgesic
agent. It inhibit the cellular expression of cyclooxygenase-2
and inducible nitric oxide by suppression of NF-kappaB
activation, thereby inhibit downstream inflammation and
subsequent pain events [7, 17]. IL-1 is an important initi-
ator of the immune response, playing a key role in the onset
and development of a complex hormonal and cellular in-
flammatory cascade. Elevated IL-1β has been detected in
Fig. 5 Harpagoside protect against hypoxia-induced toxicity on microglial cells through HIF-α pathway: Western blot quantification. Under 3 h’
hypoxic stimulation, the p65 content within nucleus significantly increased; while the cytosol IκB-α content decreased; theses effect can be reversed by
1 h’s pre-incubation of 10−8 M harpagoside. For the HIF-α, hypoxic stimulation can significantly enhance the nuclear HIF-α presentation; while there was
no significant effect on cytosol HIF-α; theses effect can be reversed by 1 h’s pre-incubation of 10−8 M harpagoside. Intensity of individual
bands was quantified using NIH ImageJ densitometry software, and expressed relative to β-actin/histone (H3) signal, as a measure of protein relative
abundance in the different samples
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the CSF and brain parenchyma within the early hours after
brain injury in both humans and rodents [18]. IL-1 has also
been documented to play a role in neuronal degeneration.
In astrocytes, IL-1 induces IL-6 production, stimulates
iNOS activity [19], and induces the production of macro-
phage colony-stimulating factor (M-CSF). In addition, IL-1
enhances microglial activation and additional IL-1 pro-
duction, astrocyte activation, thereby establishing a self-
propagating cycle [20]. IL-6 is a multifunctional cytokine
that plays an important role in host defense, with major
regulatory effects upon the inflammatory response [21].
IL-6 belongs to the neuropoietin family of cytokines, and
it has both direct and indirect neurotrophic effects on
neurons [22]. IL-6 promotes astrogliosis, activates micro-
glia, and stimulates the production of acute phase proteins
[23]. In this study, 3 h’ hypoxia stimulates microglial cells
to up-regulate their IL-1β and IL-6 genes expression, with
its maximal effect occurred at 6 h’ culture. The pre-
incubation of 10−8 M harpagoside again can inhibit
these effects (Fig. 3).
Nitric oxide (NO) is a molecule with pleiotropic effects in
different tissues. NO is a well-known vasorelaxant agent,
but it works as a neurotransmitter when produced by neu-
rons and is also involved in defense functions when it is
produced by immune and glial cells [24]. Glial- and
neuronal-derived iNOS-related long-term NO release
and NO-dependent peroxynitrite formation have been
demonstrated to cause neuronal dysfunction and cell
death in vitro and in vivo [25–27]. Under pathophysio-
logical conditions, NO has damaging effects. In disor-
ders involving oxidative stress, NO increases cell damage
through the formation of highly reactive peroxynitrite
[28]. In this study, 3 h’ hypoxia stimulates microglial
cells iNOS gene expression and active synthesis of NO;
the pre-incubation of harpagoside can down-regulate
hypoxia-induced iNOS gene expression and reduces the
NO production by microglial cells under hypoxic con-
dition (Fig. 4).
Hypoxia could lead to the inflammatory activation of
microglia [29]. During cerebral ischemia, hypoxia may
not only directly damage neurons, but also promote neur-
onal injury indirectly via microglia activation [30]. The
hypoxia-inducible factor-1 (HIF-1) is primarily involved
in the sensing and adapting of cells to changes in the
O2 level, which is regulated by many physiological func-
tions. The nuclear factor (NF)-kappaB transcriptional sys-
tem is a major effector pathway involved in inflammation
and innate immune responses. The flavonoid harpagoside
is found in various herbal extracts and has shown anti-
inflammatory properties. In our study, under 3 h’ hyp-
oxic stimulation, the nuclear HIF-α presentation and
the p65 content within nucleus significantly increased;
while the cytosol IκB-α content significantly decreased;
theses effect can be reversed by 1 h’s pre-incubation of
10−8 M harpagoside (Fig. 5). We report that harpagoside
significantly blocks hypoxia-induced I-kappa-B phosphoryl-
ation/degradation, and NF-kappa-B transcriptional activity
in mice microglial cells. Modulation of innate immunity by
natural plant products may represent an attractive strategy
to prevent inflammation associated with neuron dysfunc-
tion mediated by activated microglia [31].
Flavonoids and their polymers constitute a large class
of food constituents, many of which alter metabolic pro-
cesses and have a positive impact on health [32]. Flavo-
noids are a subclass of polyphenols. Microglia are innate
immune cells in the central nervous system. Activated
microglia can produce various proinflammatory cyto-
kines and nitric oxide (NO), which may exert neurotoxic
effects. To search for the novel therapeutic agents against
neuroinflammatory diseases, we have screened a series of
flavonoid compounds using a cell-based assay. Our studies
showed that harpagoside appear to down-regulate the gene
expression of TNF-α, interleukin (IL)-1 beta, cyclooxygen-
ase (COX-2) and inducible nitric oxide synthase (iNOS) at
mRNA levels and also may act to inhibit proinflammatory
responses [31, 33]. Harpagoside also significantly sup-
pressed I kappa B degradation, nuclear translocation of
NF-kappa B, p65 and HIF-1α. These results indicate
that harpagoside has a strong anti-inflammatory activ-
ity in brain microglia, and could be a potential thera-
peutic agent for the treatment of neuroinflammatory
diseases [33].
Although flavonoid-rich diets and flavonoid adminis-
tration prevent cognitive impairment associated with in-
flammation in animal studies [34], dietary bioactives have
potential to restore the population of microglial cells in the
senescent brain to a more quiescent state because neuroin-
flammation and cognitive deficits are co-morbid factors in
many chronic inflammatory diseases [35]. However, retro-
spective cohort studies are inconsistent in showing an
inverse association between dietary flavonoid intake and de-
mentia or neurodegenerative disease risk in humans [36].
Thus, future human studies (ideally randomized clinical
trials) will be required. These studies should involve sup-
plementation with relatively high doses of specific purified
flavanoids to shed light to the apparent inverse risk rela-
tionship with neurodegenerative diseases and also to deter-
mine if such compounds are therapeutically beneficial.
Conclusions
Hypoxia occurs when oxygen availability drops below the
levels necessary to maintain normal rates of metabolism.
Because of its high metabolic activity, the brain is highly
sensitive to hypoxia. Hypoxia could lead to microglia acti-
vation and toxic inflammatory mediators’ overproduction.
Those inflammatory molecules could amplify the neuroin-
flammatory process and exacerbate neuronal injury. In
this study, we found that harpagoside could suppress the
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microglial TNF-α, IL-1β, iNOS, COX-2 and IL-6 mRNA
expression and lower microglia nitric oxide production.
The above experimental data indicated that harpagoside
could reduce microglia inflammatory mediators’ overpro-
duction. In addition, the anti-inflammatory mechanism of
harpagoside might be associated with the transcription
factor nuclear factor kappa B (NF-κB) signaling pathway.
Harpagoside could decrease IκB-α protein phosphoryl-
ation and inhibit p65 protein translocation from the cyto-
sol to the nucleus, thus suppress NF-κB activation and
reduce the HIF-1α generation (Fig. 6).
In vitro screening for bioactive components is well estab-
lished as a means for searching potential candidates in vivo.
However, these predictions are based on observation from
in vitro experiments, some un-perceived mistakes (such as
commonly encountered uncertainties and sources of bias
and error) of a compound can lead to an inaccurate predic-
tion of an in vivo interaction. The results from this in vitro
study is still provocative and too few to draw definitive
conclusions. Further supporting data from many in vitro
mechanistic studies and in vivo studies will convincingly
show their potential effects of this bioactive molecule and
then sufficiently tantalize to justify large-scale clinical
intervention studies. This intervention, however, is im-
portant because we do contribute a major new insights
into the molecular mechanisms that regulate the oxygen-
sensitivity of HIF, and in the development of compounds
with which to manipulate HIF activity, are forcing serious
consideration of HIF as a therapeutic target for diverse
CNS disorders associated with hypoxia [37]. However,
the mechanisms of harpagoside have not been completely
understood and the facts need to be validated by further
studies both in vitro and in vivo.
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